Brief: Phasebio Announces Case Study Highlighting Pb1046 Hemodynamic Data
04/02/2020 21:45
Feb 4 (Reuters) - PhaseBio Pharmaceuticals Inc PHAS.O :
* PHASEBIO ANNOUNCES CASE STUDY HIGHLIGHTING PB1046
HEMODYNAMIC
DATA PRESENTED AT THE 14TH PULMONARY VASCULAR RESEARCH INSTITUTE
WORLD CONGRESS
Source text for Eikon: ID:nGNX7qQdpf
Further company coverage: PHAS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on PhaseBio Pharmaceuticals
See all newsBrief: Phasebio Pharmaceuticals Says Bankruptcy Court Entered Order Approving 1st Amended Combined Disclosure Statement & Chapter 11 Plan On Final Basis
U.S. RESEARCH ROUNDUP- Entegris, FedEx, Kellogg
U.S. RESEARCH ROUNDUP- Armstrong World Industries, Eli Lilly, Netflix
U.S. STOCKS ON THE MOVE-TransDigm, Vaxcyte, Tricida
PhaseBio Pharma slips on bankruptcy plans